Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children regardless of disease severity.
Andrea TaddioSara Della PaoleraLuisa AbbagnatoAnna AgrustiRaffaele BadolatoFrancesca BiscaroRoberta CaorsiAlessandro ConsolaroRosa Maria Delle PianeMarianna FabiIlenia FlorettaMarco GattornoManuela GiangrecoFrancesco La TorreMaria Cristina MaggioLorenzo MambelliAngela MauroMaria Vincenza MastroliaAlessandra MeneghelDavide MontinFrancesca RicciGabriele SimoniniAndrea SmarrazzoRita SottileSara StucchiMaria TardiLucio VerdoniGianvincenzo ZuccottiFiammetta ZunicaAngelo RavelliMarco Cattalininull nullPublished in: Rheumatology (Oxford, England) (2023)
We report that early treatment with anakinra is safe and very effective in patients with severe MIS-C. In addition, our study suggests that early treatment with anakinra is the most favorable option for patients with a higher risk to develop a severe disease outcome.
Keyphrases